Sort   by:  
 Page size 
UnknownARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation.
Not available
S-EPMC11406719 | biostudies-literature
UnknownSafety, tolerability, pharmacokinetics, and pharmacodynamics of TG103 injection in participants who are overweight or obese: a randomized, double-blind, placebo-controlled, multiple-dose phase 1b study.
Not available
S-EPMC11134614 | biostudies-literature
UnknownPCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study.
Not available
S-EPMC8763618 | biostudies-literature
UnknownSingle-dose infusion of engineered viral receptor binding domain confers rapid and durable protection against viral infection.
Not available
S-EPMC12379283 | biostudies-literature
UnknownPreparation and Characterization of Antibacterial Polypropylene Meshes with Covalently Incorporated β-Cyclodextrins and Captured Antimicrobial Agent for Hernia Repair.
Not available
S-EPMC6415163 | biostudies-literature
UnknownThe mechanism of YAP/TAZ transactivation and dual targeting for cancer therapy.
Not available
S-EPMC12022045 | biostudies-literature
UnknownA functionally tunable magnetic nanochains platform for N-glycoproteomic analysis of extracellular vesicles from ultratrace biofluids.
Not available
S-EPMC12357864 | biostudies-literature
UnknownA novelly designed protein antagonist confers potent neutralization against SARS-CoV-2 variants of concern.
Not available
S-EPMC9188817 | biostudies-literature
ProteomicsPSAT1 impairs ferroptosis and reduces immunotherapy efficacy via GPX4 hydroxylation
MDA-MB-231 cells with expression of Flag-GPX4 were treated with IFNg. An immunoprecipitation assay was performed, and immunoprecipitates were subjected to masspec analysis.
ORGANISM(S): Homo Sapiens 
2025-03-01 | PXD061373 |
Sort   by:  
 Page size